You are here

COVID-19

AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M

Fierce Pharma

Mon, 02/14/22 - 10:53 am

Pfizer stalls COVID-19 vaccine app as it awaits data on third dose in young kids

Fierce Pharma

Sat, 02/12/22 - 11:58 pm

clinical trials

Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials

Motley Fool

Sat, 02/12/22 - 11:54 pm

Moderna Therapeutics

clinical trials

Omicron COVID-19 variant

Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful

Fierce Pharma

Fri, 02/11/22 - 11:48 am

monoclonal antibodies

Novavax says its vaccine is 80% effective in teens, but manufacturing questions continue to cloud future

Endpoints

Thu, 02/10/22 - 10:17 pm

clinical trials

AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world

Fierce Biotech

Thu, 02/10/22 - 10:46 am

Pascal Soriot: AstraZeneca 'on track' to hit big $40B goal, capping years-long turnaround campaign

Endpoints

Thu, 02/10/22 - 10:42 am

Pfizer’s $100bn question

EP Vantage

Thu, 02/10/22 - 10:14 am

GlaxoSmithKline's COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark

Fierce Pharma

Thu, 02/10/22 - 10:11 am

Vir Biotchnology

Prescription drug prices have increased 2.5% since pandemic began

Beckers Hospital Review

Wed, 02/9/22 - 10:49 pm

Pfizer, in a rare COVID-19 setback, dumps Paxlovid's intravenous sibling in further blow to ACTIV-3

Fierce Biotech

Wed, 02/9/22 - 10:08 am

Robots cushion omicron's blow to Q4 orthopaedic device sales

Medtech Dive

Wed, 02/9/22 - 10:04 am

robotic surgery

J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT

Fierce Pharma

Tue, 02/8/22 - 11:57 pm

drug manufacturing

Novavax's vaccine rollout crawls amid months of broken promises — report

Endpoints

Tue, 02/8/22 - 11:53 pm

COVID-19 treatments earned 4 drugmakers $14B in 2021

Beckers Hospital Review

Tue, 02/8/22 - 11:50 pm

Gilead Sciences

Pfizer's Covid-19 vaccine captures the most annual sales of any medical product ever — by more than $15B

Endpoints

Tue, 02/8/22 - 10:12 am

Easier-To-Produce Room Temperature Covid Shot Shows Promise In Early Clinical Trials

Forbes

Tue, 02/8/22 - 10:04 am

Akston Biosciences

RedHill’s oral drug boosts Veklury efficacy in severe COVID

Pharmaforum

Tue, 02/8/22 - 09:54 am

Redhill Biopharma

Gilead Sciences

Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?

Motley Fool

Sat, 02/5/22 - 12:04 pm

Sanofi's Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter

Fierce Pharma

Fri, 02/4/22 - 01:06 pm

Pages